110 related articles for article (PubMed ID: 8392987)
1. [Concepts of the mechanisms of action of cyclosporin in psoriasis. A review with guidelines on therapy].
Mrowietz U
Hautarzt; 1993 Jun; 44(6):353-60. PubMed ID: 8392987
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin mutants render T lymphocytes resistant to cyclosporin A.
Zhu D; Cardenas ME; Heitman J
Mol Pharmacol; 1996 Sep; 50(3):506-11. PubMed ID: 8794888
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties?
Schreier MH; Baumann G; Zenke G
Transplant Proc; 1993 Feb; 25(1 Pt 1):502-7. PubMed ID: 7679818
[No Abstract] [Full Text] [Related]
4. [FK506 and kifunensine, new immunomodulators of microbial origin].
Izumi S; Okuhara M
Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1800-12. PubMed ID: 7692469
[No Abstract] [Full Text] [Related]
5. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
Tao X; Davis LS; Hashimoto K; Lipsky PE
J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin: not just a simple protein phosphatase.
Guerini D
Biochem Biophys Res Commun; 1997 Jun; 235(2):271-5. PubMed ID: 9199180
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin is a key signaling enzyme in T lymphocyte activation and the target of the immunosuppressive drugs cyclosporin A and FK506.
Clipstone NA; Crabtree GR
Ann N Y Acad Sci; 1993 Nov; 696():20-30. PubMed ID: 7509131
[No Abstract] [Full Text] [Related]
8. The use of ciclosporin in psoriasis.
Berth-Jones J
J Dermatolog Treat; 2005; 16(5-6):258-77. PubMed ID: 16428145
[TBL] [Abstract][Full Text] [Related]
9. Activation of nuclear factor-kappaB via T cell receptor requires a Raf kinase and Ca2+ influx. Functional synergy between Raf and calcineurin.
Kanno T; Siebenlist U
J Immunol; 1996 Dec; 157(12):5277-83. PubMed ID: 8955173
[TBL] [Abstract][Full Text] [Related]
10. Serum adenosine deaminase levels in patients with psoriasis: a prospective case-control study.
Bukulmez G; Akan T; Ciliv G
Eur J Dermatol; 2000 Jun; 10(4):274-6. PubMed ID: 10846253
[TBL] [Abstract][Full Text] [Related]
11. Signal requirements for interleukin 4 promoter activation in human T cells.
Paliogianni F; Hama N; Mavrothalassitis GJ; Thyphronitis G; Boumpas DT
Cell Immunol; 1996 Feb; 168(1):33-8. PubMed ID: 8599837
[TBL] [Abstract][Full Text] [Related]
12. Influence of systemic cyclosporin A on interleukin-2 and epidermal growth factor receptor expression in psoriatic skin lesions.
Horroccks A; Ormerod AD; Duncan JI; Thomson AW
Clin Exp Immunol; 1989 Nov; 78(2):166-71. PubMed ID: 12412743
[TBL] [Abstract][Full Text] [Related]
13. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
[TBL] [Abstract][Full Text] [Related]
14. Severe psoriasis treated with a new macrolide: everolimus.
Frigerio E; Colombo MD; Franchi C; Altomare A; Garutti C; Altomare GF
Br J Dermatol; 2007 Feb; 156(2):372-4. PubMed ID: 17223881
[TBL] [Abstract][Full Text] [Related]
15. [Cyclosporine in the treatment of psoriasis].
Bjerke JR
Tidsskr Nor Laegeforen; 1992 Sep; 112(22):2863-5. PubMed ID: 1412327
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin in psoriasis: pathophysiology and experimental data.
Mozzanica N; Pigatto PD; Finzi AF
Dermatology; 1993; 187 Suppl 1():3-7. PubMed ID: 8103687
[TBL] [Abstract][Full Text] [Related]
17. [Calcineurin inhibitors for topical therapy in psoriasis].
Wohlrab J
Hautarzt; 2006 Aug; 57(8):685-9. PubMed ID: 16841205
[TBL] [Abstract][Full Text] [Related]
18. Signal transmission between the plasma membrane and nucleus of T lymphocytes.
Crabtree GR; Clipstone NA
Annu Rev Biochem; 1994; 63():1045-83. PubMed ID: 7979236
[No Abstract] [Full Text] [Related]
19. Critical involvement of IL-12 in IFN-gamma induction by calcineurin antagonists in activated human lymphocytes.
Wittmann M; Killig C; Bruder M; Gutzmer R; Werfel T
J Leukoc Biol; 2006 Jul; 80(1):75-86. PubMed ID: 16641133
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of NF-AT signal transduction events by a dominant-negative form of calcineurin.
Muramatsu T; Kincaid RL
Biochem Biophys Res Commun; 1996 Jan; 218(2):466-72. PubMed ID: 8561779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
